コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 To address these issues, we adapted the variant call for
2 To address these issues, we advance and integrate these
3 To address these issues, we aim to develop an array of m
4 To address these issues, we aimed at establishing the Mo
5 To address these issues, we analyze influenza virus sequ
6 To address these issues, we analyzed a cohort of patient
7 To address these issues, we analyzed a large cohort of f
8 To address these issues, we analyzed gene expression in
9 To address these issues, we analyzed intra- and interspe
10 To address these issues, we analyzed otic placode induct
11 To address these issues, we analyzed the 12 G2P[4] RV is
12 To address these issues, we analyzed the behavior of a t
13 To address these issues, we analyzed the involvement of
14 To address these issues, we analyzed the phenotypes of n
15 To address these issues, we analyzed the production of p
16 To address these issues, we analyzed the role of CCR4 in
17 To address these issues, we analyzed the structure of th
18 To address these issues, we applied a combination of tra
19 To address these issues, we applied a semi-empirical app
20 To address these issues, we applied two different multiv
21 To address these issues, we are developing a scaffold sh
22 To address these issues, we assembled a group of multidi
23 To address these issues, we built a comprehensive and cu
24 To address these issues, we captured, sequenced, and rec
25 To address these issues, we characterized LDLR-deficient
26 To address these issues, we combined analyte recognition
27 To address these issues, we combined pharmacological mod
28 To address these issues, we combined single-pulse transc
29 To address these issues, we combined two-photon microsco
30 To address these issues, we compared CD8 T-cell response
31 To address these issues, we compared in a murine model a
32 To address these issues, we compared nuclear DNA from 32
33 To address these issues, we compared the survival of isl
34 To address these issues, we comprehensively analyzed per
35 To address these issues, we comprehensively evaluated th
36 To address these issues we conducted genetic simulations
37 To address these issues, we conducted a multicenter pros
38 To address these issues, we conducted a multicentre, ran
39 To address these issues, we conducted a prospective, obs
40 To address these issues, we convened a European Committe
41 To address these issues we created Decibel, a Python too
42 To address these issues, we created a mouse model in whi
43 To address these issues, we created a murine knockout of
44 To address these issues, we created lupus-predisposed mi
45 To address these issues, we created mice transgenic for
46 In order
to address these issues, we decided to focus on formamid
47 To address these issues we define a set of quantitative
48 To address these issues, we derive a framework for deter
49 To address these issues, we derive measures of complex p
50 To address these issues, we derive the average velocity
51 To address these issues, we describe an integrated strat
52 To address these issues, we describe here the synthesis,
53 To address these issues, we describe the development of
54 To address these issues, we describe the use of differen
55 To address these issues, we design brush-like macromolec
56 To address these issues, we designed and produced a synt
57 To address these issues, we designed transgenic mice exp
58 To address these issues, we designed two diets: a low-fa
59 To address these issues we determined the conservation o
60 To address these issues, we determined the bilayer-modif
61 To address these issues, we determined the crystal struc
62 To address these issues, we determined the effect of AGS
63 To address these issues we develop and test a method bas
64 To address these issues, we develop a model that explici
65 In order
to address these issues, we develop a new method for ped
66 To address these issues, we develop a novel approach for
67 To address these issues, we develop a protocol to combin
68 To address these issues, we develop a suite of tools for
69 To address these issues, we develop GBAT, a powerful gen
70 To address these issues, we develop the open-source soft
71 To address these issues we developed a chemical method t
72 To address these issues we developed a general strategy
73 To address these issues we developed a method for DECOnv
74 To address these issues we developed a statistical metho
75 To address these issues, we developed a biodegradable na
76 To address these issues, we developed a chain transfer p
77 To address these issues, we developed a coisogenic mouse
78 To address these issues, we developed a coordinated set
79 To address these issues, we developed a fast ligand iden
80 To address these issues, we developed a microdialysis te
81 To address these issues, we developed a mouse Hes1(CreER
82 To address these issues, we developed a multilocus Wrigh
83 To address these issues, we developed a new algorithm--C
84 To address these issues, we developed a new indexing dat
85 To address these issues, we developed a novel approach c
86 To address these issues, we developed a protocol that al
87 To address these issues, we developed a single molecule
88 To address these issues, we developed a single-cell DNA
89 To address these issues, we developed a technology terme
90 To address these issues, we developed a TRPV4 patient da
91 To address these issues, we developed an approach that m
92 To address these issues, we developed an approach, which
93 To address these issues, we developed an easy-to-use sof
94 To address these issues, we developed an efficient and r
95 To address these issues, we developed an immediate chrom
96 To address these issues, we developed an innovative assa
97 To address these issues, we developed an integrated capi
98 To address these issues, we developed and characterized
99 To address these issues, we developed and evaluated a na
100 To address these issues, we developed and locally manufa
101 To address these issues, we developed CDvist (a comprehe
102 To address these issues, we developed culture conditions
103 To address these issues, we developed gLOD-a test of co-
104 To address these issues, we developed Lipostar, novel ve
105 To address these issues, we developed PLINK, an open-sou
106 To address these issues, we developed RABiTPy, an open-s
107 To address these issues, we developed RepeatFS, a file s
108 To address these issues, we developed the ENIGMA (Enhanc
109 To address these issues, we developed the GenoTyper for
110 To address these issues, we developed the software Prost
111 To address these issues, we developed TRIBE (targets of
112 To address these issues, we developed two independent co
113 To address these issues, we developed two phylogenetic m
114 To address these issues, we disrupted glucose sensing in
115 To address these issues, we employ a 208-residue modular
116 To address these issues, we employ random matrix theory
117 To address these issues we employed a zebrafish line tha
118 To address these issues, we employed plastid genome data
119 To address these issues, we engineer self-deliverable RN
120 To address these issues, we engineered mammalian cells w
121 To address these issues, we engineered triple knock-in m
122 To address these issues, we enhanced the Swin Transforme
123 To address these issues, we established endodermal proge
124 To address these issues, we examined aspects of proteoto
125 To address these issues, we examined GLUT4 mRNA and prot
126 To address these issues, we examined the generation of b
127 To address these issues, we examined the influence of an
128 To address these issues, we examined the mPFC of 14-d-ol
129 In order
to address these issues, we exploited the site-specific
130 To address these issues, we explored the use of negative
131 To address these issues, we exposed Moina dubia to lead
132 To address these issues, we expressed SNAP-tagged IP(3)R
133 To address these issues, we expressed the light-sensitiv
134 To address these issues, we first construct a thermal pr
135 To address these issues, we first defined the promoter r
136 To address these issues, we first devised a strategy to
137 To address these issues, we first investigated the anter
138 To address these issues, we first present a novel machin
139 To address these issues, we functionally cloned a putati
140 To address these issues we generated a theoretical model
141 To address these issues we generated transgenic lines th
142 To address these issues, we generated 75 ancient mitocho
143 To address these issues, we generated a conditional Wnt1
144 To address these issues, we generated a Drosophila model
145 To address these issues, we generated a new line of tran
146 To address these issues, we generated a pancreas-specifi
147 To address these issues, we generated a recombinant aden
148 To address these issues, we generated a transcriptome fr
149 To address these issues, we generated an array of site-d
150 To address these issues, we generated knockin mice that
151 To address these issues, we generated the largest ant mo
152 To address these issues, we generated transgenic mice ex
153 To address these issues, we had participants watch a ful
154 To address these issues we have (1) introduced a correct
155 To address these issues we have demonstrated that antige
156 To address these issues we have designed surrogate preBC
157 To address these issues we have developed Predictive Net
158 To address these issues we have established and optimise
159 To address these issues we have fabricated and character
160 To address these issues we have generated a transgenic m
161 In order
to address these issues we have systematically examined
162 To address these issues we have taken a combination of p
163 To begin
to address these issues, we have carried out a rigorous
164 To address these issues, we have carried out an extensiv
165 To address these issues, we have characterized the compl
166 To address these issues, we have created knock-in mice i
167 To address these issues, we have demonstrated that chemi
168 To address these issues, we have developed a freely acce
169 To address these issues, we have developed a green fluor
170 To address these issues, we have developed a low-cost ph
171 To address these issues, we have developed a mutation de
172 To address these issues, we have developed a new two-col
173 To address these issues, we have developed a novel condi
174 To address these issues, we have developed a novel flow
175 Methods:
To address these issues, we have developed a radiolabele
176 To address these issues, we have developed a rare varian
177 To address these issues, we have developed an encapsulat
178 To address these issues, we have developed an intuitive
179 To address these issues, we have developed Gene set anal
180 To address these issues, we have developed MARQUIS-Multi
181 To address these issues, we have developed Orthologous M
182 In order
to address these issues, we have developed the Mapped Re
183 To address these issues, we have devised conditions for
184 To address these issues, we have employed genetically al
185 To address these issues, we have examined the expression
186 To address these issues, we have examined, for the first
187 To address these issues, we have focused on the rpoD gen
188 To address these issues, we have generated a transgenic
189 To address these issues, we have harnessed the power of
190 To address these issues, we have identified a site at wh
191 To address these issues, we have initiated a Phase I Exp
192 To address these issues, we have investigated the role o
193 To address these issues, we have investigated the spatio
194 To begin
to address these issues, we have performed a pilot study
195 To address these issues, we have searched for phages who
196 To address these issues, we have studied interactions be
197 To address these issues, we have studied the intracellul
198 To address these issues, we have used gene targeting to
199 To address these issues, we have used liposomes (SDLs) c
200 To address these issues, we have used the sensitive tech
201 To address these issues, we have used three different st
202 To address these issues, we here analyzed synaptic trans
203 To address these issues, we here introduce a novel, magg
204 To address these issues, we herein leverage the presence
205 To address these issues, we herein report site-specific
206 To address these issues, we identified LY3154207 (3) as
207 To address these issues, we immunodepleted precursor GLU
208 To address these issues, we implanted osmotic minipumps
209 To address these issues, we implemented PharmacoGx, an e
210 To address these issues, we introduce a novel adaptive s
211 To address these issues, we introduce a quantum-inspired
212 To address these issues, we introduce a somatic rubber-h
213 To address these issues, we introduce and benchmark thre
214 To address these issues, we introduce EfficientPoseSegNe
215 To address these issues, we introduce iCares, a wearable
216 To address these issues, we introduce Impeller, a path-b
217 To address these issues, we introduce magnetic nanoparti
218 To address these issues, we introduce novel nanolaminate
219 To address these issues, we introduce OpenABC, a softwar
220 To address these issues, we introduce RamanSPy, an open-
221 To address these issues we introduced the light-gated al
222 To address these issues, we introduced 'vertical arrays'
223 To address these issues, we investigated a new coating c
224 To address these issues, we investigated local circuits
225 To address these issues, we investigated the localizatio
226 To address these issues, we investigated the roles of mi
227 In an effort
to address these issues, we investigated the value of pa
228 To address these issues, we investigated whether (i) con
229 To address these issues we made mutants of alpha1-protei
230 To address these issues we manipulated Eda-A1 transgene
231 To address these issues, we measured gene expression lev
232 To address these issues, we measured the mutant fitness
233 To address these issues, we monitored how siRNA mediated
234 To address these issues we performed a domain-function s
235 To address these issues, we performed a longitudinal pro
236 To address these issues, we performed a proteome-wide mo
237 To address these issues, we performed a systematic liter
238 To address these issues, we performed extensive mutation
239 To address these issues, we performed functional magneti
240 To address these issues, we performed genome-wide associ
241 To address these issues, we performed in situ hybridizat
242 To address these issues, we performed in utero electropo
243 To address these issues, we performed molecular dynamics
244 Here,
to address these issues, we performed time-resolved cryo
245 To address these issues, we present an "H-noise" algorit
246 To address these issues, we probed the signaling pathway
247 To address these issues, we propose the formation of a t
248 Here,
to address these issues, we provide guidelines and recom
249 To address these issues, we quantitated virus-specific C
250 Here,
to address these issues, we quantitatively characterized
251 To address these issues we recently developed a reliable
252 Here,
to address these issues, we reconstruct molecular reprog
253 To address these issues, we recorded from the OFC while
254 To address these issues, we recorded multielectrode cort
255 To address these issues, we recorded simultaneously from
256 To address these issues, we recorded simultaneously in s
257 To address these issues, we recorded the activity of aud
258 To address these issues, we reexamined ventricular model
259 To address these issues, we replaced one bHLH gene with
260 To address these issues we report the crystal structure
261 To address these issues, we screened for epigenetic regu
262 To address these issues, we screened for genetic variant
263 To begin
to address these issues, we sought to identify T reg cel
264 To address these issues, we stably transfected several c
265 To address these issues, we studied 43 cases of cutaneou
266 To address these issues, we studied blood eosinophils fr
267 To address these issues, we studied fluctuation-based mo
268 To address these issues, we studied morphological and el
269 To address these issues, we studied the effects of CCR5
270 To address these issues, we studied the frequency and lo
271 To address these issues, we studied the morphometry and
272 To address these issues, we studied three Mrgprd knock-i
273 To address these issues, we synthesized a set of pai-ext
274 To address these issues, we synthesized oligonucleotides
275 To address these issues, we systematically mutated the T
276 To address these issues, we targeted bioactive TGF-beta(
277 To address these issues, we tested a variety of EBNA-LP
278 To address these issues, we tested human and monkey subj
279 To address these issues, we tested the preference for ob
280 To address these issues, we took advantage of the link b
281 To address these issues, we trained four subjects to per
282 To address these issues, we transplanted mouse ES cell-d
283 To address these issues, we use modeling approaches comb
284 To address these issues, we used a ClpS affinity column
285 To address these issues, we used a feline immunodeficien
286 To address these issues, we used a pheromone-inducible r
287 To address these issues, we used an induced model of mur
288 To address these issues, we used an outdoor array of mar
289 To begin
to address these issues, we used combinatorial library c
290 To address these issues, we used discrete microdissectio
291 To address these issues, we used human-derived retinal p
292 To address these issues, we used in vivo and in vitro ex
293 To address these issues, we used information on female g
294 To address these issues, we used protein similarity netw
295 To address these issues, we used purified (125)I-gp120s
296 To address these issues, we used single-event functional
297 To address these issues, we used single-RNA fluorescent
298 To address these issues, we used transretinal recordings
299 To address these issues, we used two mutants called A4 a
300 To address these issues, we utilized mass cytometry to c